Multicenter Evaluation of Ultra-Rapid Lispro (URLi) Insulin with Control-IQ Technology in Adults, Adolescents and Children with Type 1 Diabetes.
Levy C, Bailey R, Laffel LM, Forlenza GP, DiMeglio LA, Hughes MS, Brown S, Aleppo G, Bhargava A, Shah V, Clements MA, Kipnes MS, Bruggeman B, Daniels M, Rodriguez H, Calhoun P, Lum J, Sasson-Katchalski R, Pinsker JE, Pollom R, Beck RW.
Levy C, et al. Among authors: bailey r.
Diabetes Technol Ther. 2024 May 2. doi: 10.1089/dia.2024.0048. Online ahead of print.
Diabetes Technol Ther. 2024.
PMID: 38696672